The global  peripheral T-cell lymphoma (PTCL) treatment market  is projected to witness strong expansion over the next decade, supported by an increasing prevalence of aggressive and rare forms of T-cell lymphoma across both developed and emerging regions. The market is expected to grow steadily, reaching approximately USD 1,294.9 million by 2035, registering a CAGR of 6.7%, according...